Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally. GL/NP/0116 GL/NP/0095 Community Guidelines: https://bit.ly/39x9gqy
View Top Employees from Alexion Pharmaceuticals, Inc.| Website | http://www.alexion.com/ |
| Ticker | NASDAQ:ALXN |
| Revenue | $6.1 billion |
| Funding | $18 million |
| Employees | 5,911 (5,911 on RocketReach) |
| Founded | 1992 |
| Address | 121 Seaport Blvd, Boston, Massachusetts 02210, US |
| Phone | (475) 230-2596 |
| Fax | (203) 271-8198 |
| Technologies |
JavaScript,
HTML,
PHP
+288 more
(view full list)
|
| Industry | Biotechnology, Pharmaceuticals, Biotechnology Research, Healthcare, Science and Engineering, Biopharmaceutical, Health Care, Complement Inhibition, Medical, Metabolic Disorders, Neurology, Rare Diseases, Research and Development, Transplant, Haematology, Nephrology |
| Keywords | Rare Disease, Biotechnology, Healthcare Service |
| Competitors | Biogen, Jazz Pharmaceuticals plc, Regeneron, Ultragenyx Brasil, Vertex Pharmaceuticals |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 54 Companies, NAICS Code 3254 Companies, NAICS Code 541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Alexion Pharmaceuticals, Inc. employee's phone or email?
Alexion Pharmaceuticals, Inc. Questions
The Alexion Pharmaceuticals, Inc. annual revenue was $6.1 billion in 2024.
Sean Christie is the CFO of Alexion Pharmaceuticals, Inc..
5,911 people are employed at Alexion Pharmaceuticals, Inc..
Alexion Pharmaceuticals, Inc. is based in Boston, Massachusetts.
The NAICS codes for Alexion Pharmaceuticals, Inc. are [32541, 54, 3254, 541, 32, 325].
The SIC codes for Alexion Pharmaceuticals, Inc. are [28, 283].
Top Alexion Pharmaceuticals, Inc. Employees
-
15+
Related Companies
